Search Main Menu Main Content

Choose language
Change contrast :
Standards Reinforced

icone

HAS profile

Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest

International relations and projects
Publications

Recherche

icone plus
My account

Email alert Subscription

Newsletter Subscription

My search

Refresh

Please fill in your email address to retrieve your email alerts subscriptions.

New subscription

Please fill in your email address to retrieve your newsletter subscriptions.

You do not have a saved search
No element in selection
Contact

1 result

Topics : Diseases and conditions
Active substance : fructose
Active substance : acide ascorbique

Topic

Diseases and conditions (1)
Plus ...
- Urologic diseases (1)
- Plus ...
  - Kidney diseases (1)

Practice Guidelines and Other Guides (1)
Plus ...
- Practice guidelines (1)

Français (1)

Active substance

acide ascorbique (1)
chrome (1)
ciclosporine (1)
cisplatine (1)
flucytosine (1)
fructose (1)
gadolinium (1)
iode (1)
iohexol (1)
lithium (1)
phosphate (1)
phosphore (1)
tacrolimus (1)

Practice guidelines and other guides - 1 result

Diagnosis of chronic renal failure in adults

Practice guidelines - Posted on 1/9/2002

Download abstract

Add to my selection

Advancing quality in the fields of health and social care services

Follow us :

Eunetha.eu
Pasq.eu

All our publications by topic and type

Opinions on medicines
Opinions on medical devices
INAHTA briefs

Français
English

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

Sehg45ntrRd7amL1